ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients
NCT03121092 is an interventional trial sponsored by State University of New York - Downstate Medical Center. As of 18 Nov 2026, it was terminated. It studies ACEI or ARB in Hypertension and Hypotension. The registry lists an enrollment of 188 participants at 1 site in 1 country. The registry lists a start date of 16 May 2012 and a primary completion date of 7 Mar 2017.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03121092 |
| Status | Terminated |
| Study type | Interventional trial |
| Lead sponsor | State University of New York - Downstate Medical Center |
| Enrollment | 188 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Hypertension and Hypotension |
| Drugs | ACEI or ARB |
| Start | 16 May 2012 |
| Primary completion | 7 Mar 2017 |
| Study completion | 7 Mar 2017 |
| Last update posted | 19 Apr 2017 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ketan Shevde, MD
State University of New York - Downstate Medical Center
Principal Investigator - Rebecca Twersky, MD, MPH
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Suny Downstate Medical Center
Brooklyn
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT03121092
Each answer restates registry values shown on this page.
What is NCT03121092?
NCT03121092 is an interventional trial sponsored by State University of New York - Downstate Medical Center. It studies ACEI or ARB in Hypertension and Hypotension.
Who leads NCT03121092?
The registry names Ketan Shevde, MD (principal investigator, State University of New York - Downstate Medical Center) and Rebecca Twersky, MD, MPH (principal investigator, Memorial Sloan Kettering Cancer Center) as overall officials.
Where does NCT03121092 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT03121092 study?
The registered drug and biological interventions are ACEI or ARB.
When did NCT03121092 end?
The registry lists a primary completion date of 7 Mar 2017 and a study completion date of 7 Mar 2017. The sponsor last updated the record on 19 Apr 2017.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.